Biotech Values

[vinmantoo]

Are there concerns that late stage clinical trials will be impacted by the global virus pandemic. It would seem difficult for patients / control groups to participate in trials when under pandemic related constraints. Any opinions how this might impact biotechs? Thanks.

That would indeed be bad news for clinical trials and for patients involved in them and for investors in companies relying on clinical trials. Also consider that if hospitals get overwhelmed by COVID-19 patients, people with other medical issues an emergencies will be in big trouble.